2011
DOI: 10.5603/fhc.2011.0073
|View full text |Cite
|
Sign up to set email alerts
|

Expression of estrogen receptors in the pelvic floor of pre- and post-menopausal women presenting pelvic organ prolapse

Abstract: The precise role of estrogen in the pathogenesis of pelvic organ prolapse (POP) is still unclear, while the results concerning the effect of selective estrogen receptor modulators on pelvic organ prolapse are contradictory. Our aim was to test whether alteration in the expression of estrogen receptors in the pelvic floor of preand post-menopausal women is related to genital prolapse status. The mRNA levels of ERa and ERb in 60 biopsy specimens were measured. Significantly higher expression of ERa and higher ER… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 31 publications
0
8
0
Order By: Relevance
“…Adult cancer survivors, including survivors of breast cancer, have been shown to be more likely to report urinary incontinence than those without a history of cancer [11]. Many breast cancer survivors may be faced with both age-related and potential endocrine therapy-related increases in pelvic floor disorders, including sexual dysfunction; however, limited data exist regarding these issues [1215]. As the breast cancer survivor population continues to grow, addressing therapy side effects that contribute to health-related quality of life has become a key concern.…”
Section: Introductionmentioning
confidence: 99%
“…Adult cancer survivors, including survivors of breast cancer, have been shown to be more likely to report urinary incontinence than those without a history of cancer [11]. Many breast cancer survivors may be faced with both age-related and potential endocrine therapy-related increases in pelvic floor disorders, including sexual dysfunction; however, limited data exist regarding these issues [1215]. As the breast cancer survivor population continues to grow, addressing therapy side effects that contribute to health-related quality of life has become a key concern.…”
Section: Introductionmentioning
confidence: 99%
“…Morphometric and functional alterations in these muscles are related to the onset of gynaecological and urinary dysfunctions in women, some of them modelled in experimental animals . The variation in the expression of estrogen receptors (ER) in the lower urogenital tract has been associated with some pelvic dysfunctions . Estrogen replacement therapy is commonly prescribed for the treatment of pelvic dysfunctions; however, its efficacy is controversial .…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4] The variation in the expression of estrogen receptors (ER) in the lower urogenital tract has been associated with some pelvic dysfunctions. [4][5][6][7][8] Estrogen replacement therapy is commonly prescribed for the treatment of pelvic dysfunctions; however, its efficacy is controversial. 9 The effect of the estrogen administration on periurethral skeletal muscles has been previously approached, 6,8,10,11 although some issues regarding their estrogenic sensitivity remain to be addressed.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[12][13][14] Therefore, the main goal of this case-control study was to investigate MMPs, ADAMTSs, and TIMPs changes in vaginal tissue of a homogenous group of premenopausal Caucasian patients with POP and asymptomatic control women. Since reproductive hormones can modulate the turnover of pelvic floor connective tissue, [15][16][17] we have controlled our study groups according to the stage of the menstrual cycle. We hypothesized that proteinase expression and activity would be altered in vaginal tissue of younger women with POP when compared to age-matched asymptomatic control women.…”
Section: Introductionmentioning
confidence: 99%